Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
San Bernardino Urological Associates Medical Group is a premier urology practice and clinical research center serving the Inland Empire region of Southern California. Established in 1985, the group specializes in comprehensive urological care, including urologic oncology, robotic surgery, and the treatment of complex conditions such as prostate cancer, kidney stones, and bladder disorders. The practice is distinguished by its robust clinical research department, which has conducted over 500 industry and federally funded clinical trials since its inception in 1998. This research has contributed to the FDA approval of significant therapies, including Xtandi, Zytiga, and Provenge. With multiple locations across San Bernardino, Riverside, and the High Desert, the group provides patients with access to cutting-edge medical treatments and advanced surgical techniques.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on San Bernardino Urological Associates Medical Group.